BioAge
1 Follower
About
BIOAGE develops drugs to treat aging and its associated diseases. They are backed by Andreessen Horowitz, AME Cloud Ventures, PEAR Ventures, Felicis Ventures, Caffeinated Capital, and others. They have created a unique computational platform that leverages proprietary omics data from large human cohorts to identify the molecular pathways that influence longevity. BIOAGE then develop drugs that target these pathway...
- Website
- Headquarters
- Industry
- Social
Team
View all (20)
Kristen Fortney
Co-Founder & CEO
Eric Morgen
Co-Founder & COO
Paul Rubin
CMO and EVP Research
Peng Leong
Chief Business Officer
Carrie-Lynn Langlais Furr
SVP Regulatory Affairs
Ralph Scarborough
VP Finance & Accounting
Robert Hughes
VP of Biochemistry
Justin Rebo
SVP Translational Aging Biology
Robert Hopkins
VP of Program Management
Patrick Martin
VP of Clinical Science
George Hartman
Senior Advisor, Chemistry
Elad Gil
Advisor, Biotechnology
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.